Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Safety and Efficacy Upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus

Version 1 : Received: 20 December 2023 / Approved: 20 December 2023 / Online: 21 December 2023 (11:15:39 CET)

A peer-reviewed article of this Preprint also exists.

Moreno, S.; Lorenzo, G.; López-Valiñas, Á.; de la Losa, N.; Alonso, C.; Charro, E.; Núñez, J.I.; Sánchez-Cordón, P.J.; Borrego, B.; Brun, A. Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus. Viruses 2024, 16, 87. Moreno, S.; Lorenzo, G.; López-Valiñas, Á.; de la Losa, N.; Alonso, C.; Charro, E.; Núñez, J.I.; Sánchez-Cordón, P.J.; Borrego, B.; Brun, A. Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus. Viruses 2024, 16, 87.

Abstract

The introduction of three single nucleotide mutations into the genome of the virulent RVFV ZH548 strain allows the rescue of a fully attenuated virus in mice (ZH548-rA2). These mutations are located in the viral genes encoding the RdRp and the non-structural protein NSs. This paper shows the results obtained after subcutaneous inoculation of ZH548-rA2 in adult sheep and subsequent challenge with the parental virus (ZH548-rC1). Inoculation with ZH548-rA2 virus caused no detectable clinical or pathological effect in sheep, whereas inoculation of the parental rC1 virus caused lesions compatible with viral infection characterized by the presence of scattered hepatic necrosis. Viral infection was confirmed by immunohistochemistry, with hepatocytes within the necrotic foci appearing as the main cells immunolabelled against viral antigen. Furthermore, inoculation of sheep with rA2 virus prevented the liver damage expected after rC1 virus inoculation, suggesting a protective efficacy in sheep which correlated with the induction of both humoral and cell mediated immune responses.

Keywords

Rift Valley fever virus; attenuating mutations; vaccine efficacy; sheep pathology

Subject

Biology and Life Sciences, Virology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.